Synthesis and anti-HIV-1 activity of novel 10-thiaisoalloxazines, a structural analog of C-5 and/or C-6 substituted pyrimidine acyclonucleoside. 2003

Takanori Miyashita, and Masanori Baba, and Shiro Shigeta, and Kenya Mori, and Kazuo Shinozuka
Biochemical Division, Yamasa Corporation, Chiba, Japan.

A series of novel 10-thiaisoalloxazine derivatives bearing an alkoxymethyl or benzyloxymethyl moiety at the N-1 position has been synthesized through the bromination of 1-substituted-5-hydroxyuracils and subsequent condensation with aminobenzenethiol in a one-pot reaction. Contrary to the previous report, the formation of intermediary 5,6-diethoxy-5-hydroxy-5,6-dihydrouracil seems to be not the necessary factor for the formation of the thiaisoalloxazines, since the reaction proceeds in tetrahydrofuran (THF) or acetonitrile far more smoothly than in ethanol. The anti-human immunodeficiency virus (HIV)-1 activity of the resulted thiaisoalloxazine derivatives was evaluated in lymphocyte cells based on the inhibitory activity against the viral-induced cytopathic activity. Among the derivatives, compounds 6, 7, and 8 bearing an alkoxymethyl moiety at the N-1 position exhibited modest inhibitory activity towards the cytotopathic effect of HIV-1.

UI MeSH Term Description Entries
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005415 Flavins Derivatives of the dimethylisoalloxazine (7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione) skeleton. Flavin derivatives serve an electron transfer function as ENZYME COFACTORS in FLAVOPROTEINS.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Takanori Miyashita, and Masanori Baba, and Shiro Shigeta, and Kenya Mori, and Kazuo Shinozuka
February 1994, Journal of medicinal chemistry,
Takanori Miyashita, and Masanori Baba, and Shiro Shigeta, and Kenya Mori, and Kazuo Shinozuka
January 1990, Nucleic acids symposium series,
Takanori Miyashita, and Masanori Baba, and Shiro Shigeta, and Kenya Mori, and Kazuo Shinozuka
January 1991, Journal of medicinal chemistry,
Takanori Miyashita, and Masanori Baba, and Shiro Shigeta, and Kenya Mori, and Kazuo Shinozuka
January 2012, Nucleosides, nucleotides & nucleic acids,
Takanori Miyashita, and Masanori Baba, and Shiro Shigeta, and Kenya Mori, and Kazuo Shinozuka
December 2005, Bioorganic & medicinal chemistry,
Takanori Miyashita, and Masanori Baba, and Shiro Shigeta, and Kenya Mori, and Kazuo Shinozuka
January 2001, Antiviral chemistry & chemotherapy,
Takanori Miyashita, and Masanori Baba, and Shiro Shigeta, and Kenya Mori, and Kazuo Shinozuka
August 2005, Chemical & pharmaceutical bulletin,
Takanori Miyashita, and Masanori Baba, and Shiro Shigeta, and Kenya Mori, and Kazuo Shinozuka
May 2012, Molecules (Basel, Switzerland),
Takanori Miyashita, and Masanori Baba, and Shiro Shigeta, and Kenya Mori, and Kazuo Shinozuka
January 2014, Drug research,
Takanori Miyashita, and Masanori Baba, and Shiro Shigeta, and Kenya Mori, and Kazuo Shinozuka
June 2021, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!